Falmouth, MA, United States of America

Elvin A Kabat


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Elvin A Kabat: Innovator in Immunogenic Conjugate Vaccines

Introduction

Elvin A Kabat is a notable inventor based in Falmouth, MA (US). He has made significant contributions to the field of immunology, particularly in the development of T-independent conjugate vaccines. His work has implications for enhancing immune responses, especially in individuals with T-cell deficiencies.

Latest Patents

Elvin A Kabat holds a patent for "Methods relating to immunogenic dextran-protein conjugates." This invention focuses on the conception of T-independent conjugate vaccines and their application in inducing antigen-specific IgA responses. The patent demonstrates that α(1,6)dextran can elicit a markedly enhanced IgA response in T-cell free mice, showing a 20-50 fold increase compared to normal mice. Additionally, co-injection of this molecule with other antigens can enhance the IgA response to the co-antigen. The invention also reveals that a dextran-Gag conjugate can elicit Gag-specific IgA. This research identifies α(1,6)dextran as a carrier molecule for producing T-independent conjugates and as an adjuvant for enhancing IgA production. The T-independent property of these conjugates makes them particularly useful in vaccinations against HIV and other infectious and non-infectious diseases associated with T-cell deficiency.

Career Highlights

Elvin A Kabat is affiliated with Columbia University, where he continues to contribute to research and innovation in immunology. His work has been pivotal in advancing the understanding of immune responses and vaccine development.

Collaborations

Elvin has collaborated with notable colleagues, including Denong Wang and Bernard F Erlanger, to further his research and innovations in the field.

Conclusion

Elvin A Kabat's contributions to immunogenic conjugate vaccines represent a significant advancement in the field of immunology. His innovative work has the potential to improve vaccination strategies, particularly for individuals with compromised immune systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…